Clinical Trials Browser

Phase 2 × Colorectal Neoplasms × robatumumab × Clear all

NCT00551213 2018-08-24

A Study to Determine the Activity of Robatumumab (SCH 717454, MK-7454) in Participants With Relapsed or Recurrent Colorectal Cancer (P04721, MK-7454-003)

Phase 2 Completed

67 enrolled 12 charts

Gastrointestinal

Colorectal Neoplasms